Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) vs Enveric Biosciences, Inc. (ENVB)

A side-by-side comparison of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares and Enveric Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares logo
CUPR
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
$6M
$2.17HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Enveric Biosciences, Inc. logo
ENVB
Enveric Biosciences, Inc.
$7M
$1.47HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — CUPR vs ENVB

growth of $100 · dividends reinvested · last 1y
CUPR -93.5% (-93.5%/yr)ENVB -66.7% (-66.7%/yr)ENVB compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $1002026$7$33
CUPR ENVB

CUPR vs ENVB: by the numbers

  • •ENVB is the larger company ($7M vs $6M market cap).
  • •Both run net losses; ENVB's is the smaller (0.00% vs -9366.75% net margin).

Metrics side by side

Valuation

MetricCUPRENVB
P/B ratio1.480.81

Profitability

MetricCUPRENVB
Gross margin-1.29%0.00%
Operating margin-9154.62%0.00%
Net margin-9366.75%0.00%
ROE-92.44%-108.00%
ROIC-84.15%-107.99%

Go deeper

Full CUPR analysisFull ENVB analysisInteractive comparison tool

Dig into the metrics

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares ROEEnveric Biosciences ROECuprina Holdings (Cayman) Limited Class A Ordinary Shares operating marginEnveric Biosciences operating marginCuprina Holdings (Cayman) Limited Class A Ordinary Shares revenue growthEnveric Biosciences revenue growthCuprina Holdings (Cayman) Limited Class A Ordinary Shares free cash flowEnveric Biosciences free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.